Literature DB >> 23012896

Etiology of nasal polyps in cystic fibrosis: not a unimodal disease.

John W Steinke1, Spencer C Payne, Philip G Chen, Julie Negri, Edward B Stelow, Larry Borish.   

Abstract

OBJECTIVES: The objective was to determine whether the polyp subtypes observed in cystic fibrosis (CF)-related sinusitis were similar to those observed in non-CF-related sinusitis.
METHODS: Polyp and mucus samples were collected from CF patients who presented for sinus surgery. The polyps underwent histologic and cytochemical evaluation for the presence of lymphocyte cell populations and their respective cytokine markers. The mucus samples were evaluated for DNA content.
RESULTS: Of the polyps, 42% had an eosinophilic infiltrate, of which 80% had an additional mixed neutrophilic infiltrate. Of the remaining polyp samples, 42% did not have a granulocytic infiltrate, consistent with non-eosinophilic polyps. All samples had CD138-positive plasma cells. The mucus samples from the patients with CF showed higher extracellular DNA concentrations than did the mucus samples from patients with non-CF sinus disease.
CONCLUSIONS: Cystic fibrosis-related polyps demonstrated an eosinophil-based dichotomy similar to that of idiopathic non-CF-related polyps. Many also demonstrated neutrophilic infiltrate, indicating that chronic mucus stasis and infection complicate the disease. Agents capable of reducing extracellular DNA may help manage sinusitis in CF patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23012896      PMCID: PMC3616340          DOI: 10.1177/000348941212100904

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  24 in total

1.  Impaired clearance of apoptotic cells from cystic fibrosis airways.

Authors:  R William Vandivier; Valerie A Fadok; Carol Anne Ogden; Peter R Hoffmann; Joseph D Brain; Frank J Accurso; James H Fisher; Kelly E Greene; Peter M Henson
Journal:  Chest       Date:  2002-03       Impact factor: 9.410

Review 2.  Cystic fibrosis.

Authors:  P B Davis; M Drumm; M W Konstan
Journal:  Am J Respir Crit Care Med       Date:  1996-11       Impact factor: 21.405

3.  The otolaryngologic aspects of cystic fibrosis.

Authors:  J G Neely; G M Harrison; J F Jerger; S D Greenberg; H Presberg
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1972 Mar-Apr

4.  IL-5 synthesis is upregulated in human nasal polyp tissue.

Authors:  C Bachert; M Wagenmann; U Hauser; C Rudack
Journal:  J Allergy Clin Immunol       Date:  1997-06       Impact factor: 10.793

5.  Nasal polyps in cystic fibrosis.

Authors:  M Tos; C Mogensen; J Thomsen
Journal:  J Laryngol Otol       Date:  1977-10       Impact factor: 1.469

6.  Is nasal polyposis in cystic fibrosis a direct manifestation of genetic mutation or a complication of chronic infection?

Authors:  I De Gaudemar; P Contencin; T Van den Abbeele; A Munck; J Navarro; P Narcy
Journal:  Rhinology       Date:  1996-12       Impact factor: 3.681

7.  Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma.

Authors:  John W Steinke; Dewayne Bradley; Pablo Arango; Charles D Crouse; Henry Frierson; Stilianos E Kountakis; Monica Kraft; Larry Borish
Journal:  J Allergy Clin Immunol       Date:  2003-02       Impact factor: 10.793

8.  A clinical and pathologic study of chronic sinusitis: the role of the eosinophil.

Authors:  S L Harlin; D G Ansel; S R Lane; J Myers; G M Kephart; G J Gleich
Journal:  J Allergy Clin Immunol       Date:  1988-05       Impact factor: 10.793

9.  GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP).

Authors:  D L Hamilos; D Y Leung; D P Huston; A Kamil; R Wood; Q Hamid
Journal:  Clin Exp Allergy       Date:  1998-09       Impact factor: 5.018

10.  Degranulation of cystic fibrosis nasal polyp mast cells.

Authors:  W R Henderson; E Y Chi
Journal:  J Pathol       Date:  1992-04       Impact factor: 7.996

View more
  9 in total

Review 1.  Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Whitney W Stevens; Robert P Schleimer; Robert C Kern
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Jul-Aug

Review 2.  Chronic Rhinosinusitis in Children: Pathophysiology, Evaluation, and Medical Management.

Authors:  Jordan Heath; Larry Hartzell; Claire Putt; Joshua L Kennedy
Journal:  Curr Allergy Asthma Rep       Date:  2018-05-29       Impact factor: 4.806

Review 3.  Chronic rhinosinusitis phenotypes.

Authors:  John W Steinke; Larry Borish
Journal:  Ann Allergy Asthma Immunol       Date:  2016-09       Impact factor: 6.347

Review 4.  Phenotypes of Chronic Rhinosinusitis.

Authors:  Seong H Cho; Daniel L Hamilos; Doo Hee Han; Tanya M Laidlaw
Journal:  J Allergy Clin Immunol Pract       Date:  2020-05

Review 5.  Chronic rhinosinusitis pathogenesis.

Authors:  Whitney W Stevens; Robert J Lee; Robert P Schleimer; Noam A Cohen
Journal:  J Allergy Clin Immunol       Date:  2015-12       Impact factor: 10.793

6.  Hyaluronan synthases and hyaluronidases in nasal polyps.

Authors:  T Panogeorgou; E Tserbini; S Filou; D H Vynios; S S Naxakis; T A Papadas; P D Goumas; N S Mastronikolis
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-12-10       Impact factor: 2.503

Review 7.  Chronic rhinosinusitis and nasal polyposis in cystic fibrosis: update on diagnosis and treatment.

Authors:  Suzie Hyeona Kang; Paulo de Tarso Roth Dalcin; Otavio Bejzman Piltcher; Raphaella de Oliveira Migliavacca
Journal:  J Bras Pneumol       Date:  2015 Jan-Feb       Impact factor: 2.624

8.  A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery System in Nasal Polyps: A Randomized Control Trial.

Authors:  Ahmad Rezaeian; Amirabbas Kargoshaei; Zahra Rastegar
Journal:  Adv Biomed Res       Date:  2021-12-25

Review 9.  Immunomodulation in Cystic Fibrosis: Why and How?

Authors:  Vincent D Giacalone; Brian S Dobosh; Amit Gaggar; Rabindra Tirouvanziam; Camilla Margaroli
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.